Literature DB >> 6388614

Lymphocytic lymphoma/B-chronic lymphocytic leukaemia--an immunohistopathological study of peripheral B lymphocyte neoplasia.

S H Swerdlow, L J Murray, J A Habeshaw, A G Stansfeld.   

Abstract

Twenty seven patients with malignant lymphoma of lymphocytic type/B-chronic lymphocytic leukaemia (ML, L/B-CLL, Kiel classification) diagnosed from lymph node and splenectomy specimens were studied histologically and immunologically. Lymph node biopsies showed a diffuse effacement of normal architecture by small round lymphocytes usually with scattered proliferation centres (PC). A1 spleens showed white pulp with or without red pulp involvement, sometimes with tumour nodules present. PC-like cells or PC were only found in the white pulp or tumour nodules. Studies of 13 specimens using the ABC immunoperoxidase technique on frozen sections with a large panel of monoclonal antibodies showed that although a part of the monoclonal B cell neoplasm, the proliferation centres or splenic white pulp have a different phenotype from the surrounding cells. Some of these phenotypic changes are similar to those reported with in vitro induction of "maturation" of ML, L/B-CLL cells. The implications for normal B-cell development are discussed. In contrast to reported peripheral blood findings, T cells, predominantly of T helper phenotype in lymph nodes, were present but usually not numerous.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388614      PMCID: PMC1976971          DOI: 10.1038/bjc.1984.225

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  51 in total

1.  Histologic and immunohistochemical findings in the differential diagnosis of chronic lymphocytic leukemia of B-cell type and lymphoplasmacytic/lymphoplasmacytoid lymphoma.

Authors:  C S Papadimitriou; U Müller-Hermelink; K Lennert
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979

2.  Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood.

Authors:  R C Braylan; E S Jaffe; J W Burbach; M M Frank; R E Johnson; C W Berard
Journal:  Cancer Res       Date:  1976-05       Impact factor: 12.701

3.  Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas.

Authors:  K Nanba; E S Jaffe; R C Braylan; E J Soban; C W Berard
Journal:  Am J Clin Pathol       Date:  1977-11       Impact factor: 2.493

4.  Immunologic characterization of human malignant lymphomas.

Authors:  R J Lukes; R D Collins
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

5.  Analysis of HLA-D region-associated molecules with monoclonal antibody.

Authors:  D J Charron; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

Review 6.  Idiotypic immunoglobulin structures on blood lymphocytes in human plasma cell myeloma.

Authors:  G Holm; H Mellstedt; D Pettersson; R Biberfeld
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

7.  Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases.

Authors:  J L Preud'homme; M Seligmann
Journal:  Blood       Date:  1972-12       Impact factor: 22.113

8.  The lymph node in chronic lymphocytic leukemia.

Authors:  F R Dick; R D Maca
Journal:  Cancer       Date:  1978-01       Impact factor: 6.860

9.  Chronic lymphocytic leukaemia: Clonal origin in a committed B-lymphocyte progenitor.

Authors:  P J Fialkow; V Najfeld; A L Reddy; J Singer; L Steinmann
Journal:  Lancet       Date:  1978-08-26       Impact factor: 79.321

10.  Malignant lymphoma, small lymphocytic type: a clinicopathologic study of 84 cases with suggested criteria for intermediate lymphocytic lymphoma.

Authors:  H L Evans; J J Butler; E L Youness
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

View more
  16 in total

1.  Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior.

Authors:  Eva Giné; Antoni Martinez; Neus Villamor; Armando López-Guillermo; Mireia Camos; Daniel Martinez; Jordi Esteve; Xavier Calvo; Ana Muntañola; Pau Abrisqueta; Maria Rozman; Ciril Rozman; Francesc Bosch; Elias Campo; Emili Montserrat
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

2.  MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.

Authors:  K Guy; P G Middleton; L J Docherty; C L De Angelis; C M Steel
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

3.  B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes.

Authors:  L Matera; R Foa; M Massaia; M Giovarelli; F Veglia; A Cesano; P Lusso; A Piazza; D Santoli
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

4.  Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.

Authors:  Joel F Gradowski; Rachel L Sargent; Fiona E Craig; Kathleen Cieply; Kim Fuhrer; Carol Sherer; Steven H Swerdlow
Journal:  Am J Clin Pathol       Date:  2012-07       Impact factor: 2.493

5.  "Well-differentiated" lymphocytic neoplasms. Immunologic findings correlated with clinical presentation and morphologic features.

Authors:  L J Medeiros; J G Strickler; L J Picker; A B Gelb; L M Weiss; R A Warnke
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

6.  Defining the borders of splenic marginal zone lymphoma: a multiparameter study.

Authors:  Scott D Dufresne; Raymond E Felgar; Rachel L Sargent; Urvashi Surti; Susanne M Gollin; Ellen D McPhail; James R Cook; Steven H Swerdlow
Journal:  Hum Pathol       Date:  2009-12-11       Impact factor: 3.466

7.  Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma.

Authors:  M E Smith; C S Holgate; J M Williamson; I Grigor; P Quirke; C C Bird
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

8.  Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.

Authors:  K Guy; R R Meehan; A E Dewar; D Larhammar
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

9.  The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.

Authors:  P Möller; B Lämmler; B Herrmann; H F Otto; G Moldenhauer; F Momburg
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

10.  Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.

Authors:  K Guy; L J Docherty; A E Dewar
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.